The UK's COVID vaccine programme has been a standout success combining effective public investment, proactive procurement and constructive regulation. Highlighting the power of the scale of the National Health Service, of a UK Government which moves quickly and is willing to take financial risks and of a regulatory approach which puts practicality first, the programme has not simply delivered vaccines; it has acted as a catalyst for investment.